Russell Investments Group’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.07M	Buy	48,812 +2,835	+6%	+$224K	﹤0.01%	1473
2025 Q4	$3.58M	Buy	45,977 +26,986	+142%	+$1.82M	﹤0.01%	1532
2025 Q3	$1.07M	Sell	18,991 -7,709	-29%	-$348K	﹤0.01%	2176
2025 Q2	$1.17M	Sell	26,700 -55,807	-68%	-$1.92M	﹤0.01%	1993
2025 Q1	$2.26M	Buy	82,507 +23,584	+40%	+$860K	﹤0.01%	1624
2024 Q4	$2.37M	Sell	58,923 -860	-1%	-$38.8K	﹤0.01%	1589
2024 Q3	$2.83M	Buy	59,783 +6,350	+12%	+$280K	﹤0.01%	1503
2024 Q2	$1.59M	Buy	53,433 +1,676	+3%	+$58K	﹤0.01%	1750
2024 Q1	$2.08M	Buy	51,757 +2,646	+5%	+$94.7K	﹤0.01%	1630
2023 Q4	$1.25M	Buy	49,111 +17,999	+58%	+$322K	﹤0.01%	1857
2023 Q3	$432K	Buy	31,112 +12,945	+71%	+$260K	﹤0.01%	2278
2023 Q2	$418K	Sell	18,167 -9,773	-35%	-$280K	﹤0.01%	2272
2023 Q1	$828K	Sell	27,940 -979	-3%	-$31.6K	﹤0.01%	2061
2022 Q4	$722K	Buy	28,919 +5,944	+26%	+$158K	﹤0.01%	2134
2022 Q3	$498K	Buy	22,975 +2,650	+13%	+$69.8K	﹤0.01%	2247
2022 Q2	$398K	Buy	+20,325	New	+$475K	﹤0.01%	2338
2021 Q4	–	Sell	-3,699	Closed	-$217K	–	3052
2021 Q3	$217K	Buy	+3,699	New	+$214K	﹤0.01%	2751
2021 Q2	–	Sell	-24,684	Closed	-$951K	–	3260
2021 Q1	$951K	Buy	24,684 +19,705	+396%	+$1.19M	﹤0.01%	2265
2020 Q4	$357K	Buy	+4,979	New	+$243K	﹤0.01%	2556